Search details
1.
Promoter-proximal nucleosomes attenuate RNA polymerase II transcription through TFIID.
J Biol Chem
; 299(7): 104928, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37330174
2.
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.
Clin Trials
; 21(1): 29-39, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37772407
3.
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
Clin Trials
; 21(2): 189-198, 2024 04.
Article
in English
| MEDLINE | ID: mdl-37877369
4.
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions.
Childs Nerv Syst
; 2024 May 05.
Article
in English
| MEDLINE | ID: mdl-38704493
5.
The Relationship Between Choroidal Abnormalities and Visual Outcomes in Pediatric Patients With NF1-Associated Optic Pathway Gliomas.
J Neuroophthalmol
; 44(1): 5-9, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38252486
6.
Selumetinib in Children with Inoperable Plexiform Neurofibromas.
N Engl J Med
; 382(15): 1430-1442, 2020 04 09.
Article
in English
| MEDLINE | ID: mdl-32187457
7.
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1.
J Pediatr
; 260: 113513, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37244583
8.
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
J Neurooncol
; 164(3): 741-747, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37803102
9.
Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO).
Pediatr Radiol
; 53(13): 2723-2741, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37864711
10.
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Genet Med
; 24(9): 1967-1977, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35674741
11.
Guideline for Children With Cancer Receiving General Anesthesia for Procedures and Imaging.
J Pediatr Hematol Oncol
; 44(4): e859-e865, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35235547
12.
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Genet Med
; 23(8): 1506-1513, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34012067
13.
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Acta Neuropathol
; 141(4): 605-617, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33585982
14.
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
; 68(4): e28833, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33336845
15.
Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma.
Pediatr Blood Cancer
; 68(10): e29172, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34125480
16.
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e305-e316, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32502457
17.
Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.
Genet Med
; 22(11): 1794-1802, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32572180
18.
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Acta Neuropathol
; 139(2): 259-271, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31802236
19.
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Acta Neuropathol
; 139(2): 273-275, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31865440
20.
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Lancet Oncol
; 20(7): 1011-1022, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31151904